Cardiovascular Diseases in the Silesian Region in Poland.

Cardiovascular Diseases Clinical Trial

— SILICARD  

Official title:

Trends in the Incidence, Treatment and Prognosis of Cardiovascular Diseases in the Silesian Region in Poland. SILesIan CARdiovascular Database (SILICARD)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02743533
• Other study ID #: SCD016
• Status: Recruiting
• Phase: N/A
• First received: April 4, 2016
• Last updated: April 24, 2017
• Start date: January 2006
• Est. completion date: December 2021

Study information

• Verified date: April 2017
• Source: Silesian Centre for Heart Diseases
• Contact: Damian Pres, MD
• Phone: 48667288320
• Email: damianpres[@]wp.pl
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The Silesian Cardiovascular Database is an observational study of all patients hospitalized due to cardiovascular diseases. The date include information on the clinical characteristics, treatment modalities and prognosis in this population.

The data include information on all the applicable diagnostic and therapeutic procedures, prognosis and hospitalization costs. Likewise, data have been collected specialist care outpatient visits and primary health care patients were hospitalized.

Description:

The Silesian Cardiovascular Database is an prospective observational study patients who were hospitalized in the Silesian region in Poland due to cardiovascular diseases from 1st January 2006.

The aim of the study is to collect and analyze all epidemiological data, diagnostic and therapeutic procedures, in-hospital and long-term prognosis, hospitalization costs of these patients. Likewise, data have been collected specialist care outpatient visits and primary health care patients were hospitalized.

For the analysis were included patients hospitalized in the cardiology, cardiac surgery , diabetes, vascular surgery wards and who were hospitalized for cardiac diagnosis in the wards of internal medicine and intensive care.

The Silesian Cardiovascular Database was created based on the agreement between Silesian Centre for Heart Diseases in Zabrze and the Regional Department of National Health Fund in Katowice in order to conduct analyses and prepare scientific elaborations on the group of patients with circulatory system diseases. Data elaboration and preparation for analyses was conducted by the Science Department of Silesian Centre for Heart Diseases and the Department of Biostatistics of Medical University of Silesia.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10000000
• Est. completion date: December 2021
• Est. primary completion date: December 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• each hospitalisation in the departments of: cardiology, cardiac surgery, diabetology and vascular surgery,

• hospitalisation with cardiological diagnosis in the departments of internal medicine and intensive care.

Exclusion Criteria:

• hospitalisations of patients from beyond Silesia Province,

• patients at the age below18 years at the moment of admission to the hospital

Related Conditions & MeSH terms

• Cardiovascular Diseases

Locations

Country	Name	City	State
Poland	Silesian Center for Heart Diseases	Zabrze

Sponsors (1)

Lead Sponsor	Collaborator
Silesian Centre for Heart Diseases

Country where clinical trial is conducted

Poland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of participants with reported deaths from any cause		From date of inclusion until the date of death from any cause, assessed up to 1 year
Secondary	Trends in the number of hospitalization due to cardiovascular diseases		1 year
Secondary	Trends in the number of diagnostic and therapeutic procedures		1 year
Secondary	Number of participants with reported rehospitalization		From date of inclusion until the date of first event, assessed up to 1 year